Thus, RIG-I activation has been proposed as a feasible therapeutic strategy in diverse neoplasms [46, 98–100], among which NPC seems of highest interest given the role of EBV infection within further regulation of RIG-I expression in this disease [101]. Here, RIGI is linked to neoplasm.